|
|
Volumn 328, Issue 7450, 2004, Pages 1217-
|
|
Pfizer pleads guilty, but drug sales continue to soar.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ACETIC ACID DERIVATIVE;
AMINE;
CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;
GABAPENTIN;
ARTICLE;
DRUG INDUSTRY;
DRUG LABELING;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
LEGAL APPROACH;
LEGAL ASPECT;
MARKETING;
PFIZER LTD.;
UNITED STATES;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
PFIZER LTD.;
ACETIC ACIDS;
AMINES;
CYCLOHEXANECARBOXYLIC ACIDS;
DRUG INDUSTRY;
DRUG LABELING;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
MARKETING;
UNITED STATES;
|
|
EID: 2442694388
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.328.7450.1217 Document Type: Article |
|
Times cited : (29)
|
|
References (0)
|
